- Home
- PDSB
as 12-17-2024 4:00pm EST
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | PRINCETON |
| Market Cap: | 84.2M | IPO Year: | N/A |
| Target Price: | $14.00 | AVG Volume (30 days): | 403.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.16 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.53 - $6.68 | Next Earning Date: | 11-14-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest PDS Biotechnology Corporation News
PDSB Breaking Stock News: Dive into PDSB Ticker-Specific Updates for Smart Investing
GlobeNewswire
12 days ago
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
15 days ago
PDS Biotech to Host Key Opinion Leader Event on December 17 at 12 p.m. ET
MT Newswires
23 days ago
B. Riley Cuts Price Target on PDS Biotechnology to $7 From $9, Keeps Buy Rating
Zacks
a month ago
Down -35.74% in 4 Weeks, Here's Why PDS Biotechnology (PDSB) Looks Ripe for a Turnaround
GuruFocus.com
a month ago
PDS Biotechnology Corp (PDSB) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...
Associated Press Finance
a month ago
PDS Biotechnology: Q3 Earnings Snapshot
GlobeNewswire
a month ago
PDS Biotech Provides Clinical Programs Update and Reports Third Quarter 2024 Financial Results
GlobeNewswire
a month ago
PDS Biotech to Announce Third Quarter Financial Results on November 14, 2024 at 8:30 a.m. Eastern Time
Compare PDSB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PDSB PDS Biotechnology Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.